Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

184 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mepolizumab in Patients With Severe Asthma and Comorbidities: 1-Year REALITI-A Analysis.
Liu MC, Bagnasco D, Matucci A, Pilette C, Price RG, Maxwell AC, Alfonso-Cristancho R, Jakes RW, Lee JK, Howarth P. Liu MC, et al. Among authors: price rg. J Allergy Clin Immunol Pract. 2023 Dec;11(12):3650-3661.e3. doi: 10.1016/j.jaip.2023.07.024. Epub 2023 Jul 26. J Allergy Clin Immunol Pract. 2023. PMID: 37507070 Free article.
REALITI-A Study: Real-World Oral Corticosteroid-Sparing Effect of Mepolizumab in Severe Asthma.
Pilette C, Canonica GW, Chaudhuri R, Chupp G, Lee FE, Lee JK, Almonacid C, Welte T, Alfonso-Cristancho R, Jakes RW, Maxwell A, Price RG, Howarth P. Pilette C, et al. Among authors: price rg. J Allergy Clin Immunol Pract. 2022 Oct;10(10):2646-2656. doi: 10.1016/j.jaip.2022.05.042. Epub 2022 Jun 24. J Allergy Clin Immunol Pract. 2022. PMID: 35753668 Free article.
Assessment of the long-term safety of mepolizumab and durability of clinical response in patients with severe eosinophilic asthma.
Khatri S, Moore W, Gibson PG, Leigh R, Bourdin A, Maspero J, Barros M, Buhl R, Howarth P, Albers FC, Bradford ES, Gilson M, Price RG, Yancey SW, Ortega H. Khatri S, et al. Among authors: price rg. J Allergy Clin Immunol. 2019 May;143(5):1742-1751.e7. doi: 10.1016/j.jaci.2018.09.033. Epub 2018 Oct 23. J Allergy Clin Immunol. 2019. PMID: 30359681 Free article. Clinical Trial.
Prospective Italian real-world study of mepolizumab in severe eosinophilic asthma validates retrospective outcome reports.
Pini L, Caruso C, Colantuono S, Bagnasco D, Maxwell A, Price RG, Howarth P, Canonica GW; Italian investigators of REALITI‐A. Pini L, et al. Among authors: price rg. Clin Transl Allergy. 2021 Oct 14;11(8):e12067. doi: 10.1002/clt2.12067. eCollection 2021 Oct. Clin Transl Allergy. 2021. PMID: 34691389 Free PMC article. No abstract available.
184 results